SCHEMBL23917430

SCHEMBL23917430

Clc1cc(N2CCCc3ccccc32)cc(N2CCCc3c2cccc3N2CCCc3ccccc32)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
USP2 O75604 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
SPR P35270 1/20 0.43
ROCK1 Q13464 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
EPAS1 Q99814 1/20 0.40
CYP1A2 P05177 1/20 0.40
GAA P10253 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
JAK2 O60674 1/20 0.40
JAK3 P52333 1/20 0.40
PTK2 Q05397 1/20 0.40
RXRA P19793 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23917713 0.91 SPR (0.49) MAPTKDM4EUSP2ALDH1A1TSHR
SCHEMBL23908719 0.86 ROCK1 (0.43) MAPTMAPK1ROCK1SMN1; SMN2L3MBTL1
SCHEMBL23917435 0.82 ROCK1 (0.40) ALDH1A1MAPK1ROCK1SMN1; SMN2L3MBTL1
SCHEMBL23917574 0.80 ROCK1 (0.38) MAPTKDM4EUSP2ALDH1A1TSHR
SCHEMBL23917696 0.77 ALDH1A1 (0.41) MAPTKDM4EUSP2ALDH1A1TSHR
SCHEMBL8332463 0.74 SLC6A2 (0.56) CYP2C9CYP2C19EEDAVPR2
SCHEMBL693233 0.73 ROCK1 (0.51) MAPTUSP2ALDH1A1TSHRMAPK1
SCHEMBL29478502 0.73 ROCK1 (0.51) MAPTUSP2ALDH1A1TSHRMAPK1
SCHEMBL23864705 0.73 DRD2 (0.47) MAPTALDH1A1ROCK1SMN1; SMN2L3MBTL1
SCHEMBL7621219 0.73 AVPR2 (0.55) MAPTTSHRGAAGSK3BAVPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320254-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320254-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME ORAI2, SLC39A11, SLC39A7 MAPT 498/4885KDM4E 2873/4885USP2 3934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.